. 2009 May 7;45(2):157–160. doi: 10.1016/j.jcv.2009.03.014

Table 2.

Summary of available studies describing the clinical features associated with HRV-C.

Period analyzed	1999–2001	2001–2004	2003–2006	2003	2003	2004	2004–2005	2004–2005
Number of HRV-C cases	9	5	30	6	17	8	21	9
Age range	Infants	Adults	<5 years	Adults	All ages	All ages	Children	Children
Type of patient	Community	Community	Hospitalized	Hospitalized	Hospitalized and community	Community	Hospitalized	Hospitalized and community
Clinical syndromes	Asthma	Asthma	Upper and lower respiratory tract infections	Unspecified respiratory tract infections	Upper and lower respiratory tract infections	Influenza-like illness	Upper and lower respiratory tract infections	Upper respiratory tract infections, respiratory infections with wheezing or distress
Specimen analyzed	Nasal secretions	Nasal lavage	Nasopharyngeal	Throat swab	Nasopharyngeal	Narines nasopharyngeal swabs	Nasopharyngeal	Nasopharyngeal wash
Diagnosis method	RT-PCR	DNA microarray	MassTag PCR	RT-PCR	RT-PCR	PCR and MassTag PCR	RT-PCR	MassTag-PCR
Site	Wisconsin, USA	San Francisco, USA	Germany	California, USA	Australia	New York, USA	Hong Kong SAR	Colorado, USA
References	¹⁰	²⁶	¹³	⁶	¹¹	⁸	⁹	²⁷